Using a model of arrhythmias associated with ischemic left ventricular (LV) dysfunction, this study investigated autonomic and electrophysiologic mechanisms associated with sudden cardiac death (SCD) in chronic heart failure (HF). BACKGROUND Left ventricular dysfunction from ischemic heart disease is associated with many instances of SCD. Electrophysiologic and autonomic derangements occur in HF, but their contribution to SCD risk is poorly understood.
Patients with chronic heart failure (HF), most commonly the result of ischemic heart disease (1), are at risk for sudden cardiac death (SCD) arising from malignant ventricular tachyarrhythmias (2, 3) . A large body of evidence describes left ventricular (LV) mechanical remodeling leading to death from irreversible pump failure (4 -6), but little is known about electrical remodeling of the ischemic heart with LV dysfunction leading to SCD in patients who otherwise have few congestive symptoms (7) . Recent trials (8 -10) document the efficacy of antiadrenergic therapy in reducing SCD in patients with HF and demonstrate a critical role of sympathetic activity in arrhythmogenesis in the failing ventricle. However, specific mechanisms by which antiadrenergic therapy reduces lethal arrhythmias are not clear.
This limited understanding of SCD mechanisms is partly due to a lack of appropriate animal models of HF suitable for studying the arrhythmia process over time (11) . The most common large animal model of HF induces LV dysfunction with high-rate pacing (11) . Pacing-induced mechanical dysfunction, however, spontaneously resolves shortly after pacing is terminated (11) , which makes it less suitable for chronic evaluation. Furthermore, the very nature of tachycardia-induced LV dysfunction directly relates to nonischemic dilated cardiomyopathies, and extrapolation of arrhythmia mechanisms from this model to ischemic HF may be inappropriate. Finally, seldom is SCD predictable in most large animal models of HF, which hinders accurate conclusions about mechanisms that actually lead to lethal arrhythmias. Canine models of chronic ischemic heart disease and LV dysfunction have described important aspects of ventricular remodeling and nonlethal arrhythmogenesis (12) (13) (14) (15) , but several important questions about life-threatening arrhythmias in chronic LV dysfunction remain unanswered. This report describes the characteristics of a new canine model designed to address mechanisms of SCD during moderate chronic LV dysfunction arising from ischemic heart disease. Autonomic and repolarization abnormalities associated with spontaneous SCD were investigated in two discrete groups of dogs with very different spontaneous arrhythmia development during progression from myocardial infarction (MI) to HF.
METHODS

Surgical preparation.
The novel model of chronic ischemic HF reported here is partly based on an established conscious dog model of post-MI SCD (16) . Mongrel dogs were instrumented with an anterior MI by ligation of the left anterior descending artery during thoracotomy under general anesthesia. A Doppler flow probe and vascular occluder were placed around the circumflex, and a catheter was placed in the descending aorta. Each animal received immediate postoperative short-term analgesia (pentazocine lactate, 1 mg/kg, intramuscularly) followed by a longer acting analgesic (nalbuphine HCl, 0.5 mg/kg, intramuscularly). Guidelines outlined by the National Institutes of Health, American Physiological Society and the American Heart Association pertaining to the appropriate care and use of animals were strictly followed. Thirty days of recovery and acclimation to the facilities and personnel were allowed before any testing was started. Baroreflex sensitivity (BRS). All animals were acclimated to the testing environment and personnel. Baroreflex sensitivity was measured according to published methods (17) . The slope of a regression line relating phenylephrineinduced blood pressure rise to RR interval slowing defined BRS, and only significant correlations (R Ͼ 85%) were used. Baroreflex sensitivity testing was performed 30 days after MI but before the exercise and ischemia test and before the microembolization procedures. Risk for ventricular fibrillation after MI with normal LV function. To evaluate the post-MI risk for lethal arrhythmias during transient ischemia 30 days after MI, each dog exercised in a submaximal stress test protocol as previously published (16) . When target heart rate was reached (210 to 220 beats/min), the circumflex occluder was inflated for 2 min: the animals continued to run during the first minute and exercise was stopped during the second minute. Dogs developing ventricular fibrillation (VF) during the 2 min of myocardial ischemia lost consciousness and then were defibrillated. These animals were labeled "susceptible" or "highrisk" for VF. The remaining animals did not develop sustained ventricular arrhythmias and were labeled "resistant" or "low-risk" for VF. This protocol is associated with a Ͼ90% reproducibility of risk status (18) . Microembolization to produce chronic LV dysfunction. Ischemic LV dysfunction was produced by repeated microembolization of the circumflex coronary artery using a method previously described (12) . Instrumented and characterized post-MI dogs were sedated for each embolization procedure with propafol (1 mg/kg, to effect, intravascularly). The left or right femoral artery was isolated using sterile technique over local anesthesia with lidocaine (2 to 3 cc, 1% solution, SQ). A purse-string suture (4-O silk) was placed in the artery wall, and a small arteriotomy was made with an 18-gauge needle. A 6.5F introducer sheath system (Daig Corp., Minnetonka, Minnesota) was advanced into the lumen of the artery over a wire. Using a 6.0F Judkins left 3.5 diagnostic coronary catheter (Medtronic, Inc., Danvers, Missouri), the left main coronary artery was engaged under fluoroscopic guidance. The left circumflex coronary artery was identified and subselected using angiographic contrast.
Once the circumflex coronary artery was engaged, 1.5 to 3 cc of 90 warmed and sonicated latex beads (2.53% solids, Polysciences, Inc., Warrington, Pennsylvania) were slowly injected and flushed into the artery. The catheter was removed and the purse-string suture closed to ensure hemostasis. The wound was closed with 2-0 absorbable suture, and skin staples were placed. The electrocardiogram (ECG) was monitored during the procedure and for 30 min after embolization. Dogs recovered in a special high-flow oxygen cage and received postprocedure analgesia (nalbuphine 0.5 mg/kg, intramuscularly). The procedure was repeated weekly until the target LV ejection fraction (LVEF) was reached (LVEF approximately 35%). LV function assessment. To monitor decline of LV function, modified two and four chamber two-dimensional echocardiogram images of the heart were made from the apex of the sternum along the long-axis of the LV using a 3.5 MHz transducer. Endocardial definition was maximized and traced in both the two and four chamber views. Systolic and diastolic LV volumes and calculated LVEF were averaged from both orthogonal views. The mitral valve was interrogated using color Doppler to identify the presence of significant mitral regurgitation. Arrhythmia monitoring and QT interval measurements. Transthoracic modified lead I ECG was digitally acquired at baseline and three times a week after the target ejection fraction was reached and daily after arrhythmias appeared. Electrocardiogram recordings were performed while the animal was supine at rest during the midmorning time. The ECGs were digitized, and QT intervals were measured from QRS complexes at various cycle lengths and used to compare resistant and susceptible dogs. Eight to ten QT intervals were measured at matched RR intervals (Ϯ5 ms) after MI and periodically after LVEF reached 35 Ϯ 4%, including the last recording before death. QT intervals were consistently available in five resistant and five susceptible dogs. In order to match the higher heart rate of susceptible dogs with LV dysfunction, QT intervals in resistant dogs were measured during increased heart rate in response to routine activity in the laboratory. Additionally, QT interval measurements were made in 10 normal dogs at different heart rates obtained during routine recordings in the same conditions used for the study groups. This was done to generate normal distribution curves relating QT and RR intervals. This design avoided potential confounding influences of heart rate correction algorithms and increased the likelihood of reflecting real changes in QT measurements. Pathological examination. Postmortem analysis was performed in four susceptible and three resistant dogs to assess infarct size and pathological consequences of the microembolization. Resistant animals were euthanized by overdose of sodium pentobarbitol, and the heart was immediately excised and put in a 10% formalin solution. In susceptible dogs, hearts were excised as soon as the dog was found dead. Hearts were cut into five to six slices, 1 cm thick, were photographed, and the images were digitized. The total areas of the LV and the infarct zone were calculated using computerized software (Autodesk AutoCAD R14.0, Manchester, UK). Wall thickness was also measured. Serum catecholamines. Serum catecholamine analysis was performed by the hospital laboratory service at the University Hospital of the University of Oklahoma Health Sciences Center. Whole blood was centrifuged, and serum was eluted. The serum was immediately processed to measure total catecholamines, norepinephrine, epinephrine and dopamine. Blood was obtained after two weeks of reaching the target LVEF. Statistical analyses. Differences in QT intervals and heart rates in the same animals under different conditions (post-MI and HF ) were compared with analysis of variance (ANOVA) for repeated measures. Differences between groups for these parameters were evaluated with ANOVA.
Other comparisons, such as ejection fraction, ventricular volumes, size of MI, BRS and catecholamines were evaluated with a Student t test for group comparison. Frequency of SCD within the two groups was analyzed using the Fisher exact test. To describe the normal QT and RR interval relationship, nonlinear regression analysis was used to generate the best-fit line illustrating the relationship in normal dogs only. An alpha level of p Ͻ 0.05 was considered significant. Data are presented as mean Ϯ SD unless otherwise noted. Incidence of spontaneous arrhythmias. Incidence of SCD was significantly higher in susceptible dogs (p ϭ 0.001). This group developed premature ventricular contractions (PVCs) within days of reaching an LVEF of 35% and progressed rapidly to nonsustained then sustained ventricular tachycardia ( Fig. 1 and 2) . By eight weeks, all susceptible dogs died suddenly after having sustained or nonsustained ventricular tachycardia before their death. All animals were noted to be alive at the end of the day and were found dead in their cage the next morning. Resistant dogs developed only PVCs over a much longer period of time (24 weeks Ϯ 6 weeks of observation, Fig.  1B) , and only one dog died suddenly three weeks after reaching the target LVEF. No sustained arrhythmias were documented in the resistant dogs after production of LV dysfunction. Repolarization abnormalities, heart rate and SCD during progressive LV dysfunction. Arrhythmia progression in susceptible dogs was associated with a persistent sinus 
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This work reports two characteristics that promise to shed light on the mechanisms of SCD in ischemic HF. First, dogs with autonomic imbalances favoring the sympathetic nervous system after MI, but before LV dysfunction, rapidly developed lethal arrhythmias as ischemic heart disease progressed. Since the high-risk animals had very little "congestive" symptoms, we describe their progression as "arrhythmogenic HF." Second, dogs that died suddenly lost the ability to adapt ventricular repolarization to shortening cycle length. Left ventricular dysfunction did not differ between the two groups of animals, so the observed alteration in repolarization adaptation may represent a primary electrical remodeling specifically occurring in susceptible animals but not in resistant dogs. These findings suggest a link between pathologic autonomic control of heart rate and abnormalities of repolarization leading to SCD early in the progression of ischemic heart disease into HF. Novel animal model of ischemic HF. The model described in this study is new and combines a chronic infarct matrix with ongoing small vessel coronary disease to produce moderate levels of LV dysfunction. Stable LV dysfunction typical of this preparation allowed time to analyze repolarization abnormalities and unambiguously associate them with lethal arrhythmia development. This animal model is partially based on the experimental preparation of SCD after MI (normal LV function) developed by Schwartz, Billman and Stone (16) . Several general principles of arrhythmia mechanisms after a first MI were described in that model (16,19 -22) and were subsequently clinically validated (23, 24) .
Considering the etiology of LV, dysfunction in an experimental HF model is important since the clinical characteristics of arrhythmias in ischemic heart disease may be different from those of nonischemic origin. Ischemic HF has regional abnormalities of mechanical and electrical function adjacent to normal or hypertrophied myocardium. This heterogeneous substrate contrasts with nonischemic cardiomyopathies, which generally have global homogeneous dysfunction (11) . An important and widely used model of HF, pacing induced cardiomyopathy, accurately duplicates a homogeneous dilated cardiomyopathic process, and findings from that model are applicable to human disease (11) . However, what is lacking in the literature is a large animal HF model that duplicates the heterogeneity of ischemic HF accompanied with predictable risk for lethal arrhythmias. The model presented in this study was designed to address this gap in understanding and demonstrated very distinct differences in arrhythmia characteristics and risk based on individual autonomic control of heart rate and repolarization kinetics. Autonomic mechanisms of arrhythmogenic HF. Autonomic mechanisms found in this study challenge the traditional paradigm that sympathetic activation arises only from reflex adaptation to a loss of cardiac output in HF. The traditional neurohumoral view of HF explains why there is a relationship between circulating catecholamines, functional class and total mortality (25, 26) . Unfortunately, after This study further supports the hypothesis that cardiocardiac reflexes (27) originating from the damaged ventricle initiate adverse sympathetic activation coupled with vagal withdrawal (28) independent from hemodynamic effects. In this study, a clear association between abnormal cardiac autonomic control in susceptible subjects and a rapid progression of electrophysiological alterations was found. Although cause and effect cannot be established, these findings suggest that abnormal autonomic control of the heart may be linked to electrophysiologic derangements leading to SCD in ischemic LV dysfunction.
Clinical application of these results must be done carefully and tempered by the limitations of animal models in general. For example, epicardial vessel ligation and microembolization are intended to duplicate chronic, combined with subacute, large and small vessel coronary artery disease. This process does not exactly duplicate the chronic process of atherosclerotic coronary disease, nor does it approximate the length of human disease. Even with these limitations, however, the results suggest that there may be two groups of patients that develop ischemic LV dysfunction differentiated by their risk for SCD. Patients who exhibit "arrhythmogenic HF" may not survive LV dysfunction long enough to be involved in clinical trials. If this were true, traditional approaches to risk stratification would be applied to the survivors, who are, by definition, at relatively low-risk for SCD. In fact, the lack of accurate risk stratification by traditional means has led to large clinical trials examining the hypothesis that all patients with LV dysfunction should receive an implantable defibrillator (29) . Hopefully, a better understanding about the target populations coupled with elaboration of autonomic and electrophysiologic mechanisms of arrhythmias in ischemic HF will lead to better risk assessment. Abnormalities of repolarization. Normally, ventricular repolarization shortens when the heart rate increases. This important characteristic of the ventricle reduces the chance of excessively long QT intervals at short cycle lengths with the attendant risk for life-threatening arrhythmias. In this study, susceptible dogs quickly developed abnormal QT interval prolongation with shorter cycle lengths, which may reflect a defect in ion channels responsible for ventricular repolarization found in this group. Depressed expression of repolarizing currents occurs in ventricular myocytes both from experimental HF preparations and from human 
